International Journal of Oncology · 2004 · 29 citations · 0 references
MedicineCancer BiologyImmunologyCancer ImmunologyImmunizationVaccinologyCancer ImmunotherapyCancer VaccinesDendritic Cell BiologyImmune Response To VaccinationVaccinationViral VaccinesAnti-viral ImmunityCancer Vaccine ImmunologyE7 ExpressionE7 OncoproteinProtectionTumor-associated Antigen VaccinesVaccinia Virus VectorsViral Vector Immunogenicity
Dendritic cells (DC) enhanced the immunogenicity of recombinant vaccinia viruses (rVV) expressing the E7 protein of HPV16, a tumor-associated antigen (TAA). Immunization with DC transduced by rVV generated from strain Praha or MVA induced better protection against the growth of transplanted TC-1 tumors in C57Bl/6 mice than did immunization with either of these rVVs administered alone by the same route. Interestingly, DC transduced with a double recombinant vaccinia virus expressing E7 protein together with the Th1-polarizing cytokine IL12, which has been shown to enhance the cellular response in several other systems, induced lower anti-tumor immunity than DC transduced with rVV expressing E7 protein alone. The inhibitory effect mediated by IL12 on immunization with rVV-infected DC was dose-dependent and was observed after immunization with DC transduced with IL12-expressing rVV even at low multiplicity.